Invention Grant
- Patent Title: Anti-connexin compounds targeted to connexins and methods of use thereof
-
Application No.: US14467978Application Date: 2014-08-25
-
Publication No.: US10174316B2Publication Date: 2019-01-08
- Inventor: Wilda Laux , Colin Richard Green
- Applicant: CoDa Therapeutics, Inc.
- Applicant Address: US CA San Diego
- Assignee: OCUNEXUS THERAPEUTICS, INC.
- Current Assignee: OCUNEXUS THERAPEUTICS, INC.
- Current Assignee Address: US CA San Diego
- Agency: Duane Morris LLP
- Priority: NZ529936 20031203
- Main IPC: C07H21/02
- IPC: C07H21/02 ; C07H21/04 ; A61K31/70 ; C12N15/113 ; C12N15/11 ; A61K31/7105 ; A61K31/711 ; C12N5/00
Abstract:
Methods and compositions for modulating the activities of connexins are provided, including, for example, for use in post-surgical, trauma, or tissue engineering applications. These compounds and methods can be used therapeutically, for example, to reduce the severity of adverse effects associated diseases and disorders where localized disruption in direct cell-cell communication is desirable.
Public/Granted literature
- US20140371297A1 ANTI-CONNEXIN COMPOUNDS TARGETED TO CONNEXINS AND METHODS OF USE THEREOF Public/Granted day:2014-12-18
Information query
